New Trial Results: Kiora's KIO-301 Demonstrates Meaningful Vision Improvements in Retinitis Pigmentosa

Stock Information

KPRX (Common Stock)

NASDAQ CM
0.535 -0.005 (-0.93%)
As of Dec 8, 2023 3:52PM EDT
Previous Close 0.54
Market Cap 4,113,740
Open 0.526
Bid 0.5195
Bid Size 10
Ask Size 49
Day Low 0.51
Day High 0.535
52 Week Low 0.46
52 Week High 8.52
Volume 42,321
EPS (TTM) -4.44
NEWS
Loading RSS Feed